United States Influenza Diagnostics Market by Product Type, Distribution Channel, End User 2024-2032
                     United States Influenza 
Diagnostics Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
A c c o r d i n g  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G r o u p ,  t i t l e d  " U n i t e d  S t a t e s  I n f l u e n z a  D i a g n o s t i c s  
M a r k e t :  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  G r o w t h ,  O p p o r t u n i t y  a n d  F o r e c a s t  2 0 2 4 -
2 0 3 2 , "  t h e  U n i t e d  S t a t e s  i n f l u e n z a  d i a g n o s t i c s  m a r k e t  s i z e  i s  p r o j e c t e d  t o  e x h i b i t  a  g r o w t h  
r a t e  ( C A G R )  o f  6 . 3 0 %  d u r i n g  2 0 2 4 - 2 0 3 2 .
T h e  U n i t e d  S t a t e s  i n f l u e n z a  d i a g n o s t i c s  m a r k e t  i s  d r i v e n  b y  s e v e r a l  k e y  f a c t o r s ,  p r i m a r i l y  d u e  
Report t o  t h e  h e i g h t e n e d  a w a r e n e s s  a n d  d e m a n d  f o r  e a r l y  a n d  a c c u r a t e  d i a g n o s i s  o f  i n f l u e n z a .  O n e  
o f  t h e  p r i m a r y  d r i v e r s  i s  t h e  i n c r e a s i n g  p r e v a l e n c e  o f  i n f l u e n z a  a n d  o t h e r  r e s p i r a t o r y  
i n f e c t i o n s .  S e a s o n a l  f l u  o u t b r e a k s ,  c o u p l e d  w i t h  t h e  r i s i n g  i n c i d e n c e  o f  i n f l u e n z a - l i k e  
Highlight and i l l n e s s e s ,  h a v e  s i g n i f i c a n t l y  p u s h e d  t h e  n e e d  f o r  a d v a n c e d  d i a g n o s t i c  s o l u t i o n s .  
P u b l i c  h e a l t h  i n i t i a t i v e s  a n d  a w a r e n e s s  c a m p a i g n s  b y  g o v e r n m e n t  b o d i e s ,  s u c h  a s  t h e  C e n t e r s  
f o r  D i s e a s e  C o n t r o l  a n d  P r e v e n t i o n  ( C D C ) ,  e m p h a s i z e  t h e  i m p o r t a n c e  o f  e a r l y  d e t e c t i o n  a n d  
Description t r e a t m e n t  t o  p r e v e n t  c o m p l i c a t i o n s  a n d  r e d u c e  t r a n s m i s s i o n  r a t e s .  T h i s  h a s  l e d  t o  a  g r e a t e r  
d e m a n d  f o r  r a p i d  a n d  r e l i a b l e  d i a g n o s t i c  t e s t s  t h a t  c a n  b e  a d m i n i s t e r e d  i n  v a r i o u s  s e t t i n g s ,  
i n c l u d i n g  h o s p i t a l s ,  c l i n i c s ,  a n d  e v e n  a t - h o m e  t e s t i n g  k i t s .  F u r t h e r m o r e ,  a d v a n c e m e n t s  i n  
d i a g n o s t i c  t e c h n o l o g i e s ,  s u c h  a s  m o l e c u l a r  d i a g n o s t i c s ,  h a v e  i m p r o v e d  t h e  a c c u r a c y  a n d  
s p e e d  o f  i n f l u e n z a  t e s t i n g ,  f u r t h e r  f u e l i n g  m a r k e t  g r o w t h .
R e q u e s t  f o r  a  P D F  s a m p l e  o f  t h i s  r e p o r t :  
h t t p s : / / w w w . i m a r c g r o u p . c o m / u n i t e d - s t a t e s - i n f l u e n z a - d i a g n o s t i c s - m a r k e t / r e q u e s t s a m p l e
Report Description
Uni t ed  S t a t es  I n f l uenza  D i a gnos t i cs  M ark e t  T r end s :
Ano t h e r  s ign i f i can t  f ac t o r  d r i v i ng  t he  m ar ke t  i s  t h e  i nc r eas in g  i nves t m en t  i n  hea l t hca r e  i n f r as t r uc t u r e  and  t he  exp ans io n  
o f  d iagn os t i c  l a bo r a t o r y  ca pab i l i t i es  ac r oss  t he  Un i t e d  S t a t es .  W i t h  t he  r i se  i n  hea l t hca r e  sp end ing  an d  t h e  g r ow in g  
em p has i s  o n  p r e ven t i v e  ca r e ,  t he r e  h as  been  a  s ub s t an t i a l  i nc r ease  i n  t h e  n um b er  o f  d iagn os t i c  l a bo r a t o r i e s  eq u ipp ed  
w i t h  adva nced  t es t in g  t ec hno lo g ies .  M or eove r ,  t he  i n t eg r a t i on  o f  d ig i t a l  hea l t h  p la t f o r m s  an d  t e l em ed i c ine  ha s  en hance d  
acces s  t o  i n f l uen za  d i agno s t i cs ,  a l l o w ing  f o r  r em o t e  con su l t a t i ons  and  t es t i ng ,  w h ich  has  becom e pa r t i c u l a r l y  c r uc ia l  
du r i n g  t h e  CO VI D- 1 9  pan dem ic .  
The  pan dem ic  h as  unde r sco r ed  t he  im p o r t a nce  o f  r o bus t  d iagn os t i c  ca pab i l i t i e s ,  l ead ing  t o  a  he igh t ened  f oc us  o n  
enha nc ing  t e s t i ng  cap ac i t y  an d  ac ces s ib i l i t y .  A dd i t i on a l l y ,  t he  r i se  i n  c onsum er  awar eness  r eg a r d in g  t h e  ava i l ab i l i t y  an d  
bene f i t s  o f  f l u  d iagno s t i cs ,  su ppo r t ed  by  i n su r a nce  cov e r ag e  and  r e im bu r sem en t  p o l i c i es ,  has  a l s o  con t r i bu t e d  t o  m ar ke t  
g r ow t h .  Th e  c om b ina t i on  o f  t hes e  f ac t o r s  e nsu r es  a  s t eady  de m and  f o r  i n f l uenz a  d iagno s t i cs ,  a s  he a l t hca r e  p r ov i de r s  an d  
pa t i en t s  a l i ke  p r i o r i t i z e  ac cu r a t e  a nd  t im e ly  i d en t i f i ca t i o n  o f  i n f l ue nza  t o  m i t i ga t e  i t s  im p ac t  on  pub l i c  he a l t h .
Vi ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / un i t ed - s t a t es - i n f l ue nza - d i agn ost i c s - m arke t
Product Insights:
• Test K it and Reagents
• Instruments
• Others
 
Test Type Insights:
• Molecular Diagnost ic Tests
Report o Polymerase Chain React ion
o Isothermal Nucleic Acid Amplifi cat ion 
Segmentation Tests
o Others
• Tradit ional  Diagnost ic Tests
o Rapid Infl uenza Diagnost ic Tests
o Viral  Culture Tests
o Direct F luorescent Antibody Test
o Serological  Tests
Type of Flu Insights:
• Type A Flu
• Type B Flu
• Type C Flu
End User Insights:
Report • Hospitals 
• Diagnost ic Laboratories
Segmentation
• Others
Regional Insights:
• Northeast
• Midwest
• South
• West
How has the United States influenza diagnostics market 
performed so far and how will it perform in the coming 
years?
What has been the impact of COVID-19 on the United States 
influenza diagnostics market?
Key 
Questions What is the breakup of the United States influenza diagnostics market on the basis of product?
Answered in 
What is the breakup of the United States influenza 
the Report diagnostics market on the basis of test type?
What is the breakup of the United States influenza 
diagnostics market on the basis of type of flu?
What is the breakup of the United States influenza 
diagnostics market on the basis of end user?
What are the various stages in the value chain of the United 
States influenza diagnostics market?
What are the key driving factors and challenges in the 
United States influenza diagnostics?
Key 
What is the structure of the United States influenza 
Questions diagnostics market and who are the key players?
Answered in 
What is the degree of competition in the United States 
influenza diagnostics market?
the Report
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4    U n i t e d  S t a t e s  I n f l u e n z a  D i a g n o s t i c s  M a r k e t  -  I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     M a r k e t  D y n a m i c s
    4 . 3     I n d u s t r y  T r e n d s
    4 . 4     C o m p e t i t i v e  I n t e l l i g e n c e
5    U n i t e d  S t a t e s  I n f l u e n z a  D i a g n o s t i c s  M a r k e t  L a n d s c a p e
    5 . 1     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
    5 . 2     M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6    U n i t e d  S t a t e s  I n f l u e n z a  D i a g n o s t i c s  M a r k e t  -  B r e a k u p  b y  P r o d u c t
    6 . 1     T e s t  K i t  a n d  R e a g e n t s
        6 . 1 . 1  O v e r v i e w
        6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 2     I n s t r u m e n t s
        6 . 2 . 1  O v e r v i e w
        6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 2 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
       
    6 . 3     O t h e r s
        6 . 3 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 3 . 2  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7    U n i t e d  S t a t e s  I n f l u e n z a  D i a g n o s t i c s  M a r k e t  -  B r e a k u p  b y  
T e s t  T y p e
    7 . 1    M o l e c u l a r  D i a g n o s t i c  T e s t s
        7 . 1 . 1  O v e r v i e w
        7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 1 . 3  M a r k e t  S e g m e n t a t i o n
           7 . 1 . 3 . 1  P o l y m e r a s e  C h a i n  R e a c t i o n
Table of            7 . 1 . 3 . 2  I s o t h e r m a l  N u c l e i c  A c i d  A m p l i f i c a t i o n  T e s t s           7 . 1 . 3 . 3  O t h e r s
        7 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    7 . 2    T r a d i t i o n a l  D i a g n o s t i c  T e s t s
Contents         7 . 2 . 1  O v e r v i e w        7 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 2 . 3  M a r k e t  S e g m e n t a t i o n
           7 . 2 . 3 . 1  R a p i d  I n f l u e n z a  D i a g n o s t i c  T e s t s
           7 . 2 . 3 . 2  V i r a l  C u l t u r e  T e s t s
           7 . 2 . 3 . 3  D i r e c t  F l u o r e s c e n t  A n t i b o d y  T e s t
           7 . 2 . 3 . 4  S e r o l o g i c a l  T e s t s
        7 . 2 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
8    U n i t e d  S t a t e s  I n f l u e n z a  D i a g n o s t i c s  M a r k e t  -  B r e a k u p  b y  
T y p e  o f  F l u
    8 . 1    T y p e  A  F l u
        8 . 1 . 1  O v e r v i e w
        8 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        8 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /u n i t ed - s ta t es - i nfl uenz a -d i a gno s t
i c s -m a rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: